Real-world observations: how do triple-agonist approaches stack up against dual-agonist ones for midsection stubbornness
Hey everyone, I've been hitting the gym consistently for like two years now, mostly strength training with some cardio thrown in, but that lower belly pouch just refuses to budge no matter how clean I eat or how many planks I suffer through. It's frustrating as hell—my arms and legs look decent, but the midsection stays soft and stubborn. Lately I've been reading up on these incretin-based meds, like how the dual ones (GLP-1 plus GIP) already help a ton with overall fat loss, but I'm curious if stepping up to a triple-agonist setup (adding glucagon into the mix) actually makes a noticeable difference specifically for that hard-to-shift abdominal area. Anyone here tried both kinds or seen real differences in how they tackle visceral/midsection fat? Would love to hear honest takes, especially if you've dealt with the same annoying spot.
Man, that lower belly struggle is so relatable—mine was the exact same way even after dropping a bunch of weight. From what I've noticed messing around with these over the past year or so, the dual-agonists do a solid job shrinking overall body fat and curbing hunger big time, but the triple ones seem to kick things up with extra energy burn and maybe target deeper fat stores a bit better, like you actually feel the metabolism revving differently. I ended up checking out Retatrutide for sale Morellifit - Fat Burners Here just to read more on the research side of things (not pushing anything, just curious browsing), and it got me thinking the added glucagon angle could help chip away at that stubborn midsection more effectively than sticking to dual only. Still, sides can hit harder at first with any of them, so titration matters a lot in my experience. Everyone's body reacts uniquely though—what's worked for you guys?